Phase 2 Keratitis Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic Keratitis
Neurotrophic Keratitis
TearSolutions, Inc.54 enrolled3 locationsNCT07568730
Recruiting
Phase 2
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd48 enrolled1 locationNCT06975748
Recruiting
Phase 1Phase 2
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Neurotrophic Keratitis
Krystal Biotech, Inc.60 enrolled9 locationsNCT06999733
Recruiting
Phase 1Phase 2
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Herpes Simplex KeratitisCorneal Neovascularization
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT07329686
Recruiting
Phase 2
A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
Herpes Simplex Virus Type I Stromal Keratitis
Shanghai BDgene Co., Ltd.40 enrolled1 locationNCT06474442
Recruiting
Phase 2
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Neurotrophic Keratitis
BRIM Biotechnology Inc.12 enrolled1 locationNCT05927428